BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25736854)

  • 1. High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis.
    Narumi T; Shishido T; Otaki Y; Kadowaki S; Honda Y; Funayama A; Honda S; Hasegawa H; Kinoshita D; Yokoyama M; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Tanaka A; Woo CH; Abe J; Takeishi Y; Kubota I
    J Mol Cell Cardiol; 2015 May; 82():1-12. PubMed ID: 25736854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heat shock protein 27 attenuated doxorubicin-induced myocardial damage by reducing cardiomyocyte apoptosis, mitochondria damage and protein carbonylation].
    Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1021-6. PubMed ID: 19102918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism.
    You W; Min X; Zhang X; Qian B; Pang S; Ding Z; Li C; Gao X; Di R; Cheng Y; Liu L
    Shock; 2009 Jul; 32(1):108-17. PubMed ID: 19106822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
    Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
    Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of heat shock protein 27 reduces mortality and attenuates cardiac dysfunction induced by doxorubicin in a transgenic mouse model].
    Liu L; Zhang XJ; Qian B; Min XY; Cheng YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):595-8. PubMed ID: 17961420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.
    Herzog C; Lorenz A; Gillmann HJ; Chowdhury A; Larmann J; Harendza T; Echtermeyer F; Müller M; Schmitz M; Stypmann J; Seidler DG; Damm M; Stehr SN; Koch T; Wollert KC; Conway EM; Theilmeier G
    Cardiovasc Res; 2014 Mar; 101(3):400-10. PubMed ID: 24323314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
    Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
    Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock transcription factor 1 inhibits H₂O₂-induced cardiomyocyte death through suppression of high-mobility group box 1.
    Yu Y; Liu M; Zhang L; Cao Q; Zhang P; Jiang H; Zou Y; Ge J
    Mol Cell Biochem; 2012 May; 364(1-2):263-9. PubMed ID: 22246807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-410 is involved in mitophagy after cardiac ischemia/reperfusion injury by targeting high-mobility group box 1 protein.
    Yang F; Li T; Dong Z; Mi R
    J Cell Biochem; 2018 Feb; 119(2):2427-2439. PubMed ID: 28914970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Enolase plays a catalytically independent role in doxorubicin-induced cardiomyocyte apoptosis and mitochondrial dysfunction.
    Gao S; Li H; Feng XJ; Li M; Liu ZP; Cai Y; Lu J; Huang XY; Wang JJ; Li Q; Chen SR; Ye JT; Liu PQ
    J Mol Cell Cardiol; 2015 Feb; 79():92-103. PubMed ID: 25446184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.
    Xu H; Su Z; Wu J; Yang M; Penninger JM; Martin CM; Kvietys PR; Rui T
    J Immunol; 2010 Feb; 184(3):1492-8. PubMed ID: 20028656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice.
    Liu L; Zhang X; Qian B; Min X; Gao X; Li C; Cheng Y; Huang J
    Eur J Heart Fail; 2007 Aug; 9(8):762-9. PubMed ID: 17481944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy.
    Lai L; Chen J; Wang N; Zhu G; Duan X; Ling F
    Life Sci; 2017 Jan; 169():69-75. PubMed ID: 27633839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells.
    Shan YX; Liu TJ; Su HF; Samsamshariat A; Mestril R; Wang PH
    J Mol Cell Cardiol; 2003 Sep; 35(9):1135-43. PubMed ID: 12967636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.
    Kitahara T; Takeishi Y; Harada M; Niizeki T; Suzuki S; Sasaki T; Ishino M; Bilim O; Nakajima O; Kubota I
    Cardiovasc Res; 2008 Oct; 80(1):40-6. PubMed ID: 18558628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy.
    Wang WK; Wang B; Lu QH; Zhang W; Qin WD; Liu XJ; Liu XQ; An FS; Zhang Y; Zhang MX
    Int J Cardiol; 2014 Mar; 172(1):202-12. PubMed ID: 24485636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.
    Fisher PW; Salloum F; Das A; Hyder H; Kukreja RC
    Circulation; 2005 Apr; 111(13):1601-10. PubMed ID: 15811867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.